Holen Sie sich die Stockscreener-App
11.65
4.41%
-0.4724
Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
36.46%
13.38
|
9.803 | 9.834 | 10.19 | 8.61 |
| Operating Income/Loss |
36.46%
-13.38
|
-9.803 | -9.834 | -10.19 | -8.61 |
| Nonoperating Income/Loss |
83.77%
1.54
|
0.838 | 1.029 | 0.834 | 1.253 |
| Income/Loss From Continuing Operations Before Tax |
32.04%
-11.84
|
-8.965 | -8.805 | -9.354 | -7.357 |
| Income/Loss From Continuing Operations After Tax |
32.04%
-11.84
|
-8.965 | -8.805 | -9.354 | -7.357 |
|
Net Income/Loss
|
32.04%
-11.84
|
-8.965 | -8.805 | -9.354 | -7.357 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.72%
45.97
|
41.52 | 41.16 | 38.60 | 22.08 |
| Diluted Average Shares |
10.72%
45.97
|
41.52 | 41.16 | 38.60 | 22.08 |
| Basic Earnings Per Share |
18.18%
-0.26
|
-0.22 | -0.21 | -0.24 | -0.33 |
| Diluted Earnings Per Share |
18.18%
-0.26
|
-0.22 | -0.21 | -0.24 | -0.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):